This inventor holds 1 USPTO granted patent. Top assignees: Beckman Research Institute, City of Hope, National and Kapodistrian University of Athens. Active years: 2022.
Company Filing History:
1 out of 692 
1 out of 8 Years Active: 2022
Title: The Innovations of Panagiotis Gerolymatos: A Pioneer in Cancer Treatment
Introduction: Panagiotis Gerolymatos, an accomplished inventor based in Athens, Greece, has made significant contributions to the field of cancer treatment through his innovative research. With one patented invention to his name, he has demonstrated a commitment to advancing medical science and improving therapeutic options for patients.
Latest Patents: Gerolymatos holds a patent for "Thioindirubins," which encompasses compositions and methods aimed at treating cancer using thioindirubin derivatives. This invention showcases his dedication to addressing critical health challenges through groundbreaking research.
Career Highlights: Throughout his career, Gerolymatos has been affiliated with prominent institutions. He has worked at the City of Hope, a renowned cancer research and treatment center, and the National and Kapodistrian University of Athens, where he has contributed his expertise to academic research and innovation.
Collaborations: Gerolymatos has collaborated with notable colleagues, including Sangkil Nam and David A. Horne. These partnerships have further enriched his research endeavors, fostering an environment of shared knowledge and innovative problem-solving in the realm of cancer treatment.
Conclusion: Panagiotis Gerolymatos's work exemplifies the spirit of innovation in the fight against cancer. His dedication to research and development not only illustrates his commitment to advancing medical science but also positions him as a key figure in the ongoing battle against one of the world's most challenging diseases. With his patented work on thioindirubins, he continues to inspire future generations of inventors and researchers.